Barclays Analyst Is Bullish On Pacific Biosciences of California, Inc. (PACB) [Yahoo! Finance]
Pacific Biosciences of California, Inc. (PACB)
Last pacific biosciences of california, inc. earnings: 2/6 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.pacificbiosciences.com
Company Research
Source: Yahoo! Finance
On December 15, TheFly published that Luke Sergott, a Barclays analyst, lifted the price objective for Pacific Biosciences of California, Inc. (NASDAQ:PACB) from $1.50 to $2 and maintained an Equal Weight rating for the shares. As part of its 2026 forecast, the company modified price objectives and ratings in the life sciences and diagnostics tools area. The analyst informs investors in a research note that the final estimate cuts, improving end markets, and the fact that tools are the most undervalued space in healthcare offer a very favorable backdrop for the tools group to beat the market in 2026. Separately, last quarter's revenue came in slightly less than the company's projections, at $38.4 million, mainly due to fewer than expected Vega sales in Europe and lower than anticipated revenue on ASPs. Pacific Biosciences of California, Inc. (NASDAQ:PACB) anticipates an improvement in the fourth quarter with sequential revenue growth of about 10%. The company noted that revenue g
Show less
Read more
Impact Snapshot
Event Time:
PACB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PACB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PACB alerts
High impacting Pacific Biosciences of California, Inc. news events
Weekly update
A roundup of the hottest topics
PACB
News
- PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases [Yahoo! Finance]Yahoo! Finance
- Pacific Biosciences of California reports prelim Q4, FY revenue above estimate [Seeking Alpha]Seeking Alpha
- PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic DiseasesGlobeNewswire
- PacBio Announces Preliminary Fourth Quarter and Full Year 2025 RevenueGlobeNewswire
- PacBio HiFi Adopted as First-Line Sequencing Approach to Investigate Sudden Unexplained Death in Childhood (SUDC)GlobeNewswire
PACB
Earnings
- 11/5/25 - Beat
PACB
Sec Filings
- 1/12/26 - Form 8-K
- 11/14/25 - Form SCHEDULE
- 11/6/25 - Form 10-Q
- PACB's page on the SEC website